Updates
May, 2023
An Article About Itay&Beyond Was Published By JLM-BioCity:
Https://Jlm-Biocity.Org/Itaybeyond-Raises-2m-For-Drug-Development-Diagnostics-For-Autistic-Spectrum-Disorders-Groundbreaking-Technology/
october, 2022
We Are Happy To Announce That Our First RNA-Based Treatment For Sub-Population Of ASD (Phelan-McDermid Syndrome) Is Now Published As a PCT Patent Application.
september, 2022
We are excited to announce on our first development of brain organoids from a human sample.
September, 2022
We are happy to announce that our development for a urine fractionation device is now published as a PCT patent application.
August, 2022
We are honored to welcome to our scientific advisory team Dr. Frida Grynspan. Your experience and knowledge will be very meaningful to us.
july, 2022
Itay&Beyond received Helsinki approval to collect samples from 200 control and ASD participants at the Hadassah Medical Center in Jerusalem, and to test our technology.
May, 2022
We are excited to announce on our first development of brain organoids from a human sample.
December, 2021
We are delighted to welcome Dr. Naresh Mutukula, a world leading expert in developmental neurobiology to our scientific team.
July, 2021
We are thrilled to welcome Dr. Orit Shaked as a member to our advisory board. Orit brings great experience and knowledge to the team.
May, 2021
We Are Honored To Welcome To Our Scientific Advisory Board Prof. Ariel Tenenbaum, director of the Center for Children with Chronic Diseases at the Hadassah Medical Center.
English 
Arabic